perindopril Articles
XOMA's perindopril and amlodipine FDC meets primary endpoint in Ph III blood pressure trial
23 November 2012
XOMA acquires US rights to perindopril franchise
18 January 2012
CV Thera narrows 1st-qtr 2007 loss to $55.1M
7 May 2007
CV's fourth-quarter 2005 loss deepens 38%
13 March 2006
ASCOT redefines treatment of cardiovascular risk in hypertension
12 September 2005
Solvay/CV Thera's Aceon gets FDA decision delay
27 June 2005
Solvay files for new use of Aceon
20 December 2004
Daiichi Pharma
23 August 2004
Pretax profits down at Belgium's Solvay
18 February 2002
Solvay's Aceon reduces risk of stroke
18 June 2001
Belgium's Solvay places emphasis on growing pharmaceuticals further
12 February 2001
Profits and cash flow advances for Solvay
14 February 2000
Solvay looking for strong pharma growth
5 August 1999
Solvay licenses Teveten from SB
13 May 1999
Solvay licenses perindopril in USA
6 May 1999
FDA YEAR-END APPROVALS FOR 1993
10 January 1994
Showing 1-20 of 20 articles
- 1
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- Neovacs moving forward in rheumatoid arthritis, say analysts
